Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
microRNA-130b mimic
- Development stage
- Preclinical
- Modality
- miRNA Mimics → MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Transfection, Local
01
Overview
A microRNA-130b mimic is a synthetic double-stranded RNA oligonucleotide designed to replicate the biological activity of the endogenous microRNA miR-130b. In the context of oncology, particularly ovarian cancer research, miR-130b has been identified as a regulator of chemoresistance. Experimental studies using ovarian cancer cell lines (such as A2780) have demonstrated that transfection with miR-130b mimics can lead to decreased sensitivity to chemotherapeutic agents like cisplatin and paclitaxel. This effect is associated with the downregulation of multidrug resistance-related markers, including P-glycoprotein (P-gp) and glutathione S-transferase (GST)-π, suggesting that miR-130b plays a complex role in modulating the cellular response to cytotoxic drugs.
- Other names
- miR-130b mimicmiR130b mimicmiR 130b mimicmiRNA-130b mimicmiRNA130b mimicmiRNA 130b mimic
02
Targets
GSTP1 (Glutathione S-transferase P)ABCB1 (P-glycoprotein)
Beyond the preview
Go deeper on microRNA-130b mimic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on microRNA-130b mimic.